Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy

International Journal of Cardiology

Volumn 96, Issue 2, 2004, Pages 157-163

  Doolan, Gavin ^a   Nguyen, Lan ^a   Chung, Jessica ^a   Ingles, Jodie ^a   Semsarian, Christopher ^a,b  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Age; Cardiomyopathy; Gene polymorphism; Hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; BLOOD PRESSURE; BODY MASS; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENE DELETION; GENE MUTATION; GENOTYPE; GROUPS BY AGE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; RISK; STATISTICAL SIGNIFICANCE;

EID: 3242748308     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.05.003     Document Type: Article

References (36)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
2. J.G. Seidman and C.E. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
3. R. Liberthson Sudden death from cardiac causes in children and young adults N. Engl. J. Med. 334 1996 1039 1044
4. C. Semsarian and B.J. Maron Sudden cardiac death in the young Med. J. Aust. 176 2002 148 149
5. B.J. Maron, J. Shirani, and L.C. Poliac Sudden death in young competitive athletes. Clinical, demographic and pathological profiles JAMA 276 1996 199 204
6. J. Chung, T. Tsoutsman and C. Semsarian Hypertrophic cardiomyopathy: from gene defect to clinical disease Cell Res. 13 2003 9 20
7. H. Niimura, L. Bachinski, and S. Sangwatanaroj Mutations in the gene for human cardiac myosin binding protein C and late-onset familial hypertrophic cardiomyopathy N. Engl. J. Med. 338 1998 1248 1257
8. H. Watkins, A. Rosenzweig, and D. Hwang Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy N. Engl. J. Med. 326 1992 1108 1114
9. M. Arad, J.G. Seidman and C.E. Seidman Phenotypic diversity in hypertrophic cardiomyopathy Hum. Mol. Genet. 11 2002 2499 2506
10. C. Semsarian, B. Yu, C. Ryce, H. Washington, C. Lawrence and R. Trent Sudden cardiac death in familial hypertrophic cardiomyopathy: are benign mutations really benign? Pathology 29 1997 305 308
11. E. Wigle, H. Rakowski, and B. Kimball Hypertrophic cardiomyopathy: clinical spectrum and treatment Circulation 92 1995 1680 1692
12. Y.A. Lee and K. Lindpaintner Role of the renin-angiotensin system in hypertensive cardiac hypertrophy Eur. Heart J. 14 1993 42 48
13. F. Cambien, O. Poirier, and L. Lecerf Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction Nature 359 1992 641 644
14. X. Zhu, N. Bouzekri, and L. Southam Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphism with ACE concentration and blood pressure Am. J. Hum. Genet. 2001 1139 1148
15. G.P. Candy, D. Skudicky, and U.K. Mueller Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy Am. J. Cardiol. 83 1999 740 744
16. K. Yoneya, H. Okamoto, and M. Machida Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy Am. Heart J. 130 1995 1089 1093
17. A. Marian, Q. Yu, and R. Workman Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death Lancet 342 1993 1085 1086
18. J. Marian Modifier genes for hypertrophic cardiomyopathy Curr. Opin. Cardiol. 17 2002 242 252
19. A. Ogimoto, M. Hamada, and J. Nakura Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy J. Hum. Genet. 47 2002 184 189
20. M. Lechin, M. Quinones, and A. Omran Angiotensin-1 converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy Hypertension 38 2001 1278 1281
21. A. Ishanoov, H. Okamoto, and K. Yoneya Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy Am. Heart J. 133 1997 184 189
22. P. Spirito, P. Bellone, and K. Harris Magnitude of left ventricular predicts the risk of sudden death in hypertrophic cardiomyopathy N. Engl. J. Med. 342 2000 1778 1785
23. B. Maron, W. Shen, and M. Link Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N. Engl. J. Med. 342 2000 365 373
24. I. Jayatilleke, M. McGuire, V. Booth, D.R. Richmond and C. Semsarian Preventing sudden death in hypertrophic cardiomyopathy Heart, Lung and Circulation 12 2003 196 198
25. B. Maron, P. Spirito, and Y. Wesley Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy N. Engl. J. Med. 315 1986 610 614
26. C. Semsarian, J. French, and R. Trent The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy Aust. N.Z. J. Med. 27 1997 51 58
27. G.M. Hecht, J.A. Panza and B.J. Maron Clinical course of middle-aged asymptomatic patients with hypertrophic cardiomyopathy Am. J. Cardiol. 69 1992 935 940
28. C. Semsarian, M. Healey, and D. Fatkin A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy J. Mol. Cell. Cardiol. 33 2001 2055 2060
29. F.J. He and G.A. MacGregor Salt, blood pressure and the renin-angiotensin system J. Renin-Angiotensin Aldosterone Syst. 4 2003 11 16
30. K. Lindpaintner, M. Lee, and G.M. Larson Absence of association of genetic linkage between angiotensin-converting-enzyme gene and left ventricular mass N. Engl. J. Med. 334 1996 1023 1028
31. M. Kupari, M. Perola, P. Koskinen, J. Virolainen and P.J. Karhunen Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans Am. J. Physiol. 267 1994 1107 1111
32. N. Iwai, N. Ohmichi, Y. Nakamura and M. Kinoshita DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy Circulation 90 1994 2622 2628
33. H. Schunkert, H.W. Hense, and S.R. Holmer Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy N. Engl. J. Med. 330 1994 1634 1638
34. F. Cambien, F. Alhenc-Gelas, and B. Herbeth Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study Am. J. Hum. Genet. 43 1988 774 780
35. B. Rigat, C. Hubert, and F. Alhenc-Gelas An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J. Clin. Invest. 86 1990 1343 1346
36. D.N. Muller, J. Bohlender, and K.F. Hilgers Vascular expression of the angiotensin-converting enzyme gene regulates the rate of local angiotensin II formation Hypertension 29 1997 98 104